FR2374042A1 - Nouveau medicament immunostimulant et son procede de preparation - Google Patents
Nouveau medicament immunostimulant et son procede de preparationInfo
- Publication number
- FR2374042A1 FR2374042A1 FR7616937A FR7616937A FR2374042A1 FR 2374042 A1 FR2374042 A1 FR 2374042A1 FR 7616937 A FR7616937 A FR 7616937A FR 7616937 A FR7616937 A FR 7616937A FR 2374042 A1 FR2374042 A1 FR 2374042A1
- Authority
- FR
- France
- Prior art keywords
- preparation
- medicinal product
- immunostimulant
- new
- new immunostimulant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Médicament stimulant de l'immunité et son procédé de préparation. Il comporte l'extrait phénolosoluble avec une fraction de cet extrait, des bactéries, levures ou protozoaires. Il est utilisable soit seul, soit associé à d'autres agents actifs dans un domaine de lutte contre les agents infectieux ou pour augmenter le niveau de résistance des défenses immunitaires.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7616937A FR2374042A1 (fr) | 1976-06-04 | 1976-06-04 | Nouveau medicament immunostimulant et son procede de preparation |
NL7706174A NL7706174A (nl) | 1976-06-04 | 1977-06-03 | Immuno stimulerend geneesmiddel alsmede werkwijze voor het bereiden ervan. |
DE2725204A DE2725204C2 (de) | 1976-06-04 | 1977-06-03 | Verfahren zum Herstellen eines die unspezifische Immunität stimulierenden löslichen Mikroorganismenextrakts und diesem enthaltendes Arzneimittel |
GB23738/77A GB1583889A (en) | 1976-06-04 | 1977-06-03 | Immuno-stimulant medicament and process for its preparation |
BE178163A BE855357A (fr) | 1976-06-04 | 1977-06-03 | Nouveau medicament immunostimulant et son procede de preparation |
CA279,825A CA1091582A (fr) | 1976-06-04 | 1977-06-03 | Medicament immunostimulant et son procede de preparation |
US05/804,150 US4182751A (en) | 1976-06-04 | 1977-06-06 | New immunostimulant medicament and process of preparing same |
US06/071,591 US4337243A (en) | 1976-06-04 | 1979-08-30 | Immunostimulant medicament and process of preparing same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7616937A FR2374042A1 (fr) | 1976-06-04 | 1976-06-04 | Nouveau medicament immunostimulant et son procede de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2374042A1 true FR2374042A1 (fr) | 1978-07-13 |
FR2374042B1 FR2374042B1 (fr) | 1980-04-30 |
Family
ID=9174007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7616937A Granted FR2374042A1 (fr) | 1976-06-04 | 1976-06-04 | Nouveau medicament immunostimulant et son procede de preparation |
Country Status (7)
Country | Link |
---|---|
US (2) | US4182751A (fr) |
BE (1) | BE855357A (fr) |
CA (1) | CA1091582A (fr) |
DE (1) | DE2725204C2 (fr) |
FR (1) | FR2374042A1 (fr) |
GB (1) | GB1583889A (fr) |
NL (1) | NL7706174A (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2447193A1 (fr) * | 1979-01-25 | 1980-08-22 | Unicler | Utilisation de pichia ou d'extraits de pichia, comme medicament. |
EP0018245A1 (fr) * | 1979-03-22 | 1980-10-29 | Roussel-Uclaf | Nouveaux dérivés stéroides 7-alkylés, leur procédé de préparation, leur application comme médicament et les compositions pharmaceutiques les renfermant |
FR2477416A1 (fr) * | 1980-03-10 | 1981-09-11 | Unicler | Utilisation de hansenula ou d'extraits de hansenula, comme medicament |
FR2480604A1 (fr) * | 1980-04-22 | 1981-10-23 | Pasteur Institut | Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon et leur procede de preparation |
FR2502496A2 (fr) * | 1981-03-30 | 1982-10-01 | Pasteur Institut | Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation |
US4479935A (en) * | 1980-04-22 | 1984-10-30 | Institut Pasteur | Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK138379A (da) * | 1979-04-04 | 1980-10-05 | Nordisk Droge & Kemikalie | Vaccine imod pleuropneumonia (ondartet lungesyge) hos svin dens anvendelse samt fremgangsmaade og substat til dyrkning specielt aerob fermentering af mikroorganismen haemophilus pleuropneumoniae |
WO1981001102A1 (fr) * | 1979-10-19 | 1981-04-30 | A Romano | Remede pour le traitement des infections virales de l'oeil et d'autres organes |
JPS56135159A (en) | 1980-03-26 | 1981-10-22 | Fujirebio Inc | Immunological diagnosis method |
EP0196530A3 (fr) * | 1985-03-26 | 1989-03-22 | CTA Finanz AG | Agent et procédé pour augmenter la croissance, optimiser la fécondité et stimuler le système immunitaire chez les humains et les animaux |
WO1986006279A1 (fr) * | 1985-04-30 | 1986-11-06 | Scripps Clinic And Research Foundation | Proteine de phase aigue modulant l'activite endotoxique de lipopolysaccharides, compositions et procedes |
US4681761A (en) * | 1985-10-24 | 1987-07-21 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine |
DE3728367C1 (de) * | 1987-08-25 | 1988-09-01 | Burkhard Steglich | Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen |
US5223491A (en) * | 1989-11-09 | 1993-06-29 | Donzis Byron A | Method for revitalizing skin by applying topically water insoluble glucan |
EP0595209A3 (en) * | 1992-10-23 | 1996-07-17 | R I T A Corp An Illinois Corp | Cosmetic composition |
US5853738A (en) * | 1995-10-30 | 1998-12-29 | Dynagen, Inc. | Methods for treatment of human immunodeficiency virus infection with pseudomonas phosphoaminolipid extract |
US5851534A (en) * | 1996-05-03 | 1998-12-22 | Dynagen, Inc. | Methods for prevention and/or treatment of neutropenia |
JP2001517223A (ja) * | 1997-04-02 | 2001-10-02 | バイオニケ ライフ サイエンシーズ インコーポレイテッド | 原生動物性または寄生生物性疾患の予防、治療または排除のための細菌細胞壁抽出物の使用 |
US6183756B1 (en) | 1997-05-01 | 2001-02-06 | Dynagen, Inc. | Methods for prevention and/or treatment of thrombocytopenia |
ES2187047T3 (es) | 1997-08-05 | 2003-05-16 | Bioniche Life Sciences Inc | Composicion y metodo para la regulacion de la proliferacion celular y la muerte celular. |
MXPA02005842A (es) * | 1999-12-13 | 2003-10-14 | Bioniche Life Sciences Inc | Oligonucleotidos sinteticos terapeuticamente utiles. |
NZ520312A (en) * | 1999-12-28 | 2003-08-29 | Bioniche Life Sciences Inc | Hyaluronic acid in the treatment of cancer |
US7491517B2 (en) * | 2006-07-19 | 2009-02-17 | Jeeri R Reddy | Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135 |
CN104370997B (zh) * | 2014-09-24 | 2018-07-31 | 陈辉 | 去除生物制品中细菌内毒素的试剂盒、方法及其生物制品的制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1621118A (en) * | 1925-11-04 | 1927-03-15 | Winford P Larson | Modified bacteria and toxins, immunizing serums and method of producing them |
US1621119A (en) * | 1926-01-27 | 1927-03-15 | Winford P Larson | Scarlet fever antigen |
US2020647A (en) * | 1933-06-07 | 1935-11-12 | Hunwicke Roderick Francis | Method of manufacturing bacterial solutions |
NL63957C (fr) * | 1946-01-03 | |||
GB725938A (en) * | 1952-01-24 | 1955-03-16 | Wander A G A | Method of preparing substantially protein-free polysaccharides from micro-organisms |
US3148120A (en) * | 1952-01-24 | 1964-09-08 | Wander Ag Dr A | Hot aqueous phenol extraction of gramnegative bacterial lipopolysaccharides |
DE1175389B (de) * | 1958-07-26 | 1964-08-06 | Wander Ag Dr A | Verfahren zur Herstellung stabiler, waessriger Lipoid-Dispersionen |
GB1056839A (en) * | 1963-09-19 | 1967-02-01 | Johnson & Johnson | Brucella antigen |
GB1073694A (en) * | 1965-05-24 | 1967-06-28 | Twyford Lab Ltd | Preparation of bacterial lipopolysaccharides |
US3483290A (en) * | 1967-10-24 | 1969-12-09 | Carter Wallace | Bacterial fractions |
US3636192A (en) * | 1970-01-13 | 1972-01-18 | Us Army | Meningococcal polysaccharide vaccines |
US3859434A (en) * | 1973-01-08 | 1975-01-07 | Canadian Patents Dev | Meningococcal antigens |
US4010257A (en) * | 1973-02-23 | 1977-03-01 | Burroughs Wellcome Co. | Biological extracts |
FR2269961B1 (fr) * | 1974-05-06 | 1978-03-24 | Anvar |
-
1976
- 1976-06-04 FR FR7616937A patent/FR2374042A1/fr active Granted
-
1977
- 1977-06-03 NL NL7706174A patent/NL7706174A/xx not_active Application Discontinuation
- 1977-06-03 BE BE178163A patent/BE855357A/fr not_active IP Right Cessation
- 1977-06-03 CA CA279,825A patent/CA1091582A/fr not_active Expired
- 1977-06-03 GB GB23738/77A patent/GB1583889A/en not_active Expired
- 1977-06-03 DE DE2725204A patent/DE2725204C2/de not_active Expired
- 1977-06-06 US US05/804,150 patent/US4182751A/en not_active Expired - Lifetime
-
1979
- 1979-08-30 US US06/071,591 patent/US4337243A/en not_active Expired - Lifetime
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2447193A1 (fr) * | 1979-01-25 | 1980-08-22 | Unicler | Utilisation de pichia ou d'extraits de pichia, comme medicament. |
EP0015175A1 (fr) * | 1979-01-25 | 1980-09-03 | Univablot | Médicament constitué de Pichia ou d'extraits de Pichia |
EP0018245A1 (fr) * | 1979-03-22 | 1980-10-29 | Roussel-Uclaf | Nouveaux dérivés stéroides 7-alkylés, leur procédé de préparation, leur application comme médicament et les compositions pharmaceutiques les renfermant |
EP0018245B1 (fr) * | 1979-03-22 | 1982-06-02 | Roussel-Uclaf | Nouveaux dérivés stéroides 7-alkylés, leur procédé de préparation, leur application comme médicament et les compositions pharmaceutiques les renfermant |
FR2477416A1 (fr) * | 1980-03-10 | 1981-09-11 | Unicler | Utilisation de hansenula ou d'extraits de hansenula, comme medicament |
EP0035937A1 (fr) * | 1980-03-10 | 1981-09-16 | Univablot | Utilisation de Hansenula ou d'extraits de Hansenula, comme médicament |
FR2480604A1 (fr) * | 1980-04-22 | 1981-10-23 | Pasteur Institut | Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon et leur procede de preparation |
US4479935A (en) * | 1980-04-22 | 1984-10-30 | Institut Pasteur | Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation |
FR2502496A2 (fr) * | 1981-03-30 | 1982-10-01 | Pasteur Institut | Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation |
Also Published As
Publication number | Publication date |
---|---|
DE2725204A1 (de) | 1977-12-22 |
DE2725204C2 (de) | 1982-03-04 |
CA1091582A (fr) | 1980-12-16 |
US4337243A (en) | 1982-06-29 |
US4182751A (en) | 1980-01-08 |
NL7706174A (nl) | 1977-12-06 |
BE855357A (fr) | 1977-12-05 |
FR2374042B1 (fr) | 1980-04-30 |
GB1583889A (en) | 1981-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2374042A1 (fr) | Nouveau medicament immunostimulant et son procede de preparation | |
Osborn | Changes in BCG strains | |
SE8402551L (sv) | Cinnamoylmoranolin-derivat | |
BE862107A (fr) | Nouveaux derives de 1,4-dihydropyridine substitues en position 2, leur procede de preparation et medicament les contenant | |
BE824742A (fr) | Nouveaux composes d'indole substitues en positions 1 et 2, leur procede de preparation et les preparations pharmaceutiques les contenant | |
BE783499A (fr) | N-tertiaire aminomethyl-4' dibenzo (b,e) oxepine-11-spiro- 2'-dioxolanne-1',3', leur procede de preparation et leur application en therapeutique | |
PH10478A (en) | 3-substituted alkyleneamines having 5,6 or 7-ring members and pharmaceutical preparations containing them | |
FR2399252A1 (fr) | Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation | |
NL161434C (nl) | Werkwijze voor de bereiding van farmaceutische prepara- ten met alfa-sympathicolytische werking, gevormde pre- paraten en werkwijze voor de bereiding van aminoalkyl- tetrahydro 1-ketonaftaleenderivaten. | |
BE858356A (fr) | Derives d'acide 7-acylamino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique, leur procede de preparation et leur application en therapeutique | |
FR2334345A1 (fr) | Nouveau derive d'alcool benzylique, son procede de preparation et medicament le contenant | |
Franco et al. | Caries Removal With and Without a Disclosing Solution of Basic Fuchsin. | |
BE764166A (fr) | Nouveaux derives de l'indole, leur procede de preparation et composition therapeutique les contenant | |
BE847685A (fr) | Preparations retard en solution huileuse non saturee, et leur procede de preparation | |
BE763964A (fr) | Nouveaux derives de l'aminocarbonyl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique | |
BE882270A (fr) | Derives de benzothiazole, leur procede de preparation et leurs applications en therapeutique | |
BE860126A (fr) | Derives de 4,6-di-o-(aminoglycosyl)-1,3-diamino-cyclitols leur procede de preparation et compositions pharmaceutiques les contenant | |
BE770170A (fr) | Procede d'hydrogenation selective en plusieurs etapes de coupespetrolieres bouillant dans le domaine des essences | |
BE807065A (fr) | Nouveaux 4-spiro(cyclopropyl) androstenes leur procede de preparation et medicament les contenant | |
Budtz‐Jörgensen et al. | Leukocyte migration inhibition by dental plaque antigens as indicated by the capillary tube and the agarose plate technique | |
USD232300S (en) | Screw driver with wire stripper | |
Trimble | Gamma globulin | |
MORSE | Further Evidence for Macromolecular Nature of Human Câ ²l | |
BE804836A (fr) | Nouvelles n-(heteroarylmethyl)-desoxy-normorphines et -norcodeines, leurs sels d'addition avec des acides, leurs procedes de preparation et leur application en tant que medicaments | |
HORNE et al. | Inactivation of Spores of Bacillus anthracis by γ-Radiation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |